Strand Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Strand Therapeutics is a biotechnology research company based in Boston, Massachusetts, founded by biological engineers from the Massachusetts Institute of Technology (MIT). The company is developing mRNA-based therapies by creating an mRNA programming language and a platform for mRNA smart therapies that can program where, when, and how strongly a therapeutic protein is expressed in the body using intracellular logic circuits. The technology aims to achieve cell-type specific expression and to regulate protein dosage through responses to externally administered small molecules. Strand employs between 51 and 200 people and operates in the biotechnology research industry. In 2025, Strand announced leadership appointments and board additions, including Jason J. Luke as Chief Medical Officer and Ala Alenazi joining the board, as part of its funding and growth activities, including a Series B round.

Sign up for free to view info

Company overview Employee directory